Fortis Malar Hospitals Ltd (FORTISMLR) is currently trading at 40.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Fortis Malar Hospital Limited operates as a multi-specialty hospital, providing healthcare services in various specialized departments including cardiology, neurosurgery, and gastroenterology. In 2008, Fortis Healthcare Limited acquired Fortis Malar, changing the management and control of the company. Fortis Malar experienced significant strategic changes, leading to the transfer of its main business operations to MGM Healthcare Pvt Ltd in 2024. The hospital is known for its advanced cardio thoracic surgeries under the leadership of renowned surgeon Dr. K M Cherian. Past plans for bed capacity expansion reflect growth ambitions, although the scope and visibility of this growth remain limited.

Over the past 52 weeks, Fortis Malar Hospitals Ltd has traded between a low of ₹39.00 and a high of ₹66.99. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Fortis Malar Hospitals Ltd has a market capitalization of approximately 75.57. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Fortis Malar Hospitals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 188.92 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 75.57 Cr, Fortis Malar Hospitals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Fortis Malar Hospitals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Fortis Malar Hospitals Ltd is 188.92. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Fortis Malar sold the Malar Hospital business to MGM Healthcare Private Limited through a slump sale under a Business Transfer Agreement entered into during the year ended March 31, 2024. Its September 30, 2026 filing says the company ceased to have business operations after that transaction.

Fortis Malar reported sales of ₹0 crore for the quarter ended June 2026. Sales were also ₹0 crore in March 2026, while the company had reported ₹0.02 crore in June 2025.